Science & Technology

Ilona Yim studies the relationship between hormones and postpartum depression. Her research could help identify, treat women before onset of symptoms.

UC Irvine’s postdoctoral research staffers asked, “Where’s the love,” and the university responded, making February “Postdoc Appreciation Month.”

The state today tentatively approved $3.3 million over three years to enhance UC Irvine’s stem cell training program, which teaches tomorrow’s experts the techniques, ethics and clinical knowledge critical to this fast-growing field.

Barack Obama swept into the presidency on a platform of change, one that includes a number of scientific policy and research issues. As a major research university, UC Irvine is deeply involved in some of these key areas – stem cells, global warming and alternative energy, to name a few. Research vice chancellor Susan Bryant discusses how changes made in Washington, D.C., and Sacramento, especially during the current economic crisis, will impact research efforts at UCI.

Peter Taborek uses high-speed video to capture the motion of drops and bubbles coming apart. Knowing the details of this “pinch-off” process is important when designing inkjet printers and also is useful in biotechnology when fluid is used on microchips, as well as for applications in cosmetics, food and structural materials industries.

James Hicks and Michael Dennin could tell you a story about the ontogeny of cardiovascular regulation in reptiles and Langmuir monolayers. Or they could talk to you about the science of WALL-E and Superman.

A therapy developed at UC Irvine that made paralyzed rats walk again will become the world’s first embryonic stem cell treatment tested in humans.

Professor Hongkai Zhao uses mathematics to make computers run better, which in turn improves medical imaging and engineering design.

An insecticide used to fumigate termite-infested buildings is a strong greenhouse gas that lives in the atmosphere nearly 10 times longer than previously thought, UC Irvine research has found.

As a brain imaging researcher who studies schizophrenia, Dr. Steven Potkin saw a large problem limiting growth in his field and the potential for new clinical treatments.